Ask AI
ProCE Banner Activity

Navigating MDD Management: When to Switch, Augment, or Stay the Course

Clinical Thought

Read this commentary about major depressive disorder covering how initial adequate trials and early improvements should guide selection of augmentation or switching and how to identify the most appropriate available pharmacologic options and combine them with psychotherapy. This program offers valuable insights into identifying evidence-based strategies designed to help your patients achieve an optimal quality of life and complete functional recovery.

Released: November 11, 2025

Share

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by educational grants from AbbVie Inc. and Intra-Cellular Therapies, Inc.

AbbVie Inc.

Intra-Cellular Therapies, Inc.

Disclosure

Primary Author

Jason Tucciarone, MD, PhD, has no relevant financial relationships to disclose.